AACR – Broadening eligibility criteria for cancer clinical trials may better demonstrate how a drug will affect a real-world population

American Association for Cancer Research shared on LinkedIn:

“Broadening eligibility criteria for cancer clinical trials allows more patients to participate and may better demonstrate how a drug will affect a real-world population. Data from a recent study published in the AACR journal Clinical Cancer Research and new efforts from the FDA may help clinical researchers do this safely.”

Read further.
Source: AACR/LinkedIn